Pharmaceutical

Shrinking Covid vaccine sales has Moderna course-correcting

Shrinking Covid vaccine sales has Moderna course-correc...

Nov 3, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month

STAT+: Pharmalittle: U.S. Senate eyes more policies for...

Nov 3, 2023

And so, another working week will soon draw to a close. Not a moment too soon, y...

STAT+: Health plan formularies lowered barriers to fair access to some drugs, analysis finds

STAT+: Health plan formularies lowered barriers to fair...

Nov 3, 2023

Most of the formularies run by some of the largest health plans in the U.S. gene...

Opinion: State Prescription Drug Affordability Boards could end up limiting access to the life-saving cystic fibrosis medication Trikafta

Opinion: State Prescription Drug Affordability Boards c...

Nov 3, 2023

Colorado’s Prescription Drug Affordability Board could end up limiting access to...

A brain injury turns a writer into an ‘activated patient’ focused on the beauty of the now

A brain injury turns a writer into an ‘activated patien...

Nov 3, 2023

A patient still deals with memory loss after brain surgery: "I can't live in the...

Opinion: The best way to convince healthy people to get insurance is not ‘because it’s in your financial interest’

Opinion: The best way to convince healthy people to get...

Nov 3, 2023

Healthy people should get medical insurance, but not necessarily because it’s in...

STAT+: Medicare proceeds with plan to claw back hospital funds after Supreme Court decision

STAT+: Medicare proceeds with plan to claw back hospita...

Nov 3, 2023

Medicare officials are moving forward with a plan to claw back money from certai...

STAT+: Key Senate panel to consider PBM, drug pricing reform package

STAT+: Key Senate panel to consider PBM, drug pricing r...

Nov 3, 2023

A key Senate panel announced it will consider policies to regulate pharmacy midd...

STAT+: Inari Medical to buy last-line amputation prevention company LimFlow

STAT+: Inari Medical to buy last-line amputation preven...

Nov 3, 2023

Vascular device maker Inari Medical announced plans to buy LimFlow, a company se...

Rats have an imagination, too, researchers show with brain implants

Rats have an imagination, too, researchers show with br...

Nov 3, 2023

Rats think of objects and places that are not directly in front of them, a key r...

Listen: Decoding biotech hype, the Sarepta saga, & au r...

Nov 3, 2023

This week on "The Readout LOUD" podcast: When is a failure not a failure? Does t...

STAT+: Could kidney transplant patients be spared a lifetime of immunosuppressants?

STAT+: Could kidney transplant patients be spared a lif...

Nov 3, 2023

In a small trial, 63% of kidney transplant patients were able to discontinue imm...

Senate bill would permanently extend Covid-era rules on telehealth addiction treatment

Senate bill would permanently extend Covid-era rules on...

Nov 3, 2023

A bipartisan bill would permanently extend a Covid-era policy that allowed patie...

Camidanlumab tesirine by ADC Therapeutics for Myelodysplastic Syndrome: Likelihood of Approval

Camidanlumab tesirine by ADC Therapeutics for Myelodysp...

Nov 2, 2023

Camidanlumab tesirine is under clinical development by ADC Therapeutics and curr...

AB-1003 by Asklepios BioPharmaceutical for Limb-Girdle Muscular Dystrophy: Likelihood of Approval

AB-1003 by Asklepios BioPharmaceutical for Limb-Girdle ...

Nov 2, 2023

AB-1003 is under clinical development by Asklepios BioPharmaceutical and current...

Darovasertib by Ideaya Biosciences for Colorectal Cancer: Likelihood of Approval

Darovasertib by Ideaya Biosciences for Colorectal Cance...

Nov 2, 2023

Darovasertib is under clinical development by Ideaya Biosciences and currently i...